Financhill
Back

TScan Therapeutics Stock Price Chart

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TCRX is experiencing slight buying pressure.

TScan Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 1.63 Buy
20-day SMA: 1.56 Buy
50-day SMA: 1.5 Buy
200-day SMA: 2.76 Sell
8-day EMA: 1.15 Buy
20-day EMA: 0.59 Buy
50-day EMA: 0.27 Buy
200-day EMA: 0.07 Buy

TScan Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.4 Buy
Relative Strength Index (14 RSI): 62.32 Buy
Chaikin Money Flow: 12038 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.45 - 1.73) Buy
Bollinger Bands (100): (1.31 - 1.83) Buy

TScan Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for TScan Therapeutics Stock

Is TScan Therapeutics Stock a Buy?

TCRX Technical Analysis vs Fundamental Analysis

Sell
41
TScan Therapeutics (TCRX) is a Sell

Is TScan Therapeutics a Buy or a Sell?

TScan Therapeutics Stock Info

Market Cap:
102.4M
Price in USD:
1.81
Share Volume:
228.7K

TScan Therapeutics 52-Week Range

52-Week High:
7.89
52-Week Low:
1.02
Sell
41
TScan Therapeutics (TCRX) is a Sell

TScan Therapeutics Share Price Forecast

Is TScan Therapeutics Stock a Buy?

  • TScan Therapeutics share price is 1.81 while TCRX 8-day exponential moving average is 1.15, which is a Buy signal.
  • The stock price of TCRX is 1.81 while TScan Therapeutics 20-day EMA is 0.59, which makes it a Buy.
  • TScan Therapeutics 50-day exponential moving average is 0.27 while TCRX share price is 1.81, making it a Buy technically.
  • TCRX stock price is 1.81 and TScan Therapeutics 200-day simple moving average is 0.07, creating a Buy signal.

Fundamental Analysis of TScan Therapeutics

Is TScan Therapeutics a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.03 per share, an increase next quarter of $0.04 per share, a decrease this year of $0.11 per share, and an increase next year of $0.07 per share.

Technical Analysis of TScan Therapeutics

Should I short TScan Therapeutics stock?

* TScan Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.